跳至主要内容
临床试验/JPRN-UMIN000011419
JPRN-UMIN000011419已完成未知

Efficacy of once weekly teriparatide in patients with glucocorticoid-induced osteoporosis

Glucocorticoid-induced osteoporosis research group0 个研究点目标入组 204 人开始时间: 2013年8月8日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
204

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients who have been taking or are scheduled to take oral steroid at a dose equivalent to 5 mg/day of prednisolone or higher for at least 3 months
  • 2) Patients aged 20 years or older

排除标准

  • 1) Patients who previously used bisphosphonate. However, use for up to 2 weeks, 6 months or more before the enrollment is allowed.
  • 2) Patients who have used Teribone or Forteo in the past.
  • 3) Patients for who have contraindications of teriparatide and alendronate.
  • 4) Patients who have 3 or more lumbar vertebral bodies could not be evaluated in DXA.
  • 5) Patients who have used denosumab within the 6 months before enrollment.
  • 6) Patients who were considered as inappropriate for the study by physician.

研究者

发起方
Glucocorticoid-induced osteoporosis research group

相似试验